Nature and Wildlife Discovery Center

BioCryst and Clearside Biomedical Enter Partnership to Develop Avoralstat for Diabetic Macular Edema Using Clearside’s Proprietary SCS Microinjector®

Retrieved on: 
Friday, November 3, 2023

ALPHARETTA, Ga. and RESEARCH TRIANGLE PARK, N.C., Nov. 03, 2023 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) and Clearside Biomedical, Inc. (Nasdaq: CLSD) today announced the entry into a license agreement enabling BioCryst to develop its investigational plasma kallikrein inhibitor, avoralstat, with Clearside’s SCS Microinjector® to deliver avoralstat directly to the back of the eye through the suprachoroidal space to treat patients with diabetic macular edema (DME).

Key Points: 
  • “Many DME patients are not effectively controlled with anti-VEGF therapy, so it is exciting to target plasma kallikrein by combining avoralstat with delivery into the suprachoroidal space using Clearside’s proprietary SCS Microinjector.
  • Avoralstat has high potency and low solubility, which are two characteristics important to achieving potential efficacy with reduced dosing frequency in the eye for DME patients.
  • Avoralstat was previously evaluated in an oral formulation in a Phase 3 clinical trial in patients with hereditary angioedema (HAE).
  • “Treating patients with DME by delivering avoralstat directly to the suprachoroidal space using the SCS Microinjector expands the reach of our proprietary SCS injection platform to a greater number of patients.

NEW SEABOURN PURSUIT OFFERS UNPRECEDENTED ELEGANCE AND SPACE THAT REDEFINE ULTRA-LUXURY EXPEDITION TRAVEL

Retrieved on: 
Thursday, July 27, 2023

SEATTLE, July 27, 2023 /PRNewswire/ -- Seabourn , the leader in ultra-luxury voyages and expedition travel, is featuring unprecedented elegance and spacious public rooms and lounges aboard its second purpose-built expedition vessel Seabourn Pursuit , which is scheduled to enter service on August 12, 2023.

Key Points: 
  • SEATTLE, July 27, 2023 /PRNewswire/ -- Seabourn , the leader in ultra-luxury voyages and expedition travel, is featuring unprecedented elegance and spacious public rooms and lounges aboard its second purpose-built expedition vessel Seabourn Pursuit , which is scheduled to enter service on August 12, 2023.
  • "There is an abundance of elegance, space and offerings that will redefine ultra-luxury expedition travel, providing our guests with many Seabourn Moments they will always treasure."
  • A guest favorite across the Seabourn fleet, Seabourn Square is the true 'living room' of the line's new expedition ships.
  • The Expedition Lounge will be central to the Seabourn expedition operation where guests convene before and after expeditions each day.

SEABOURN'S NEW EXPEDITION VESSEL SEABOURN PURSUIT SHINES FOR THE ULTRA-LUXURY LINE WITH DESIGN DETAILS FOR A STUNNING DEBUT

Retrieved on: 
Thursday, July 20, 2023

SEATTLE, July 20, 2023 /PRNewswire/ -- Seabourn , the leader in ultra-luxury ocean and expedition travel, is revealing the stunning design details of its second purpose-built expedition ship, Seabourn Pursuit , scheduled to launch in August 2023.

Key Points: 
  • SEATTLE, July 20, 2023 /PRNewswire/ -- Seabourn , the leader in ultra-luxury ocean and expedition travel, is revealing the stunning design details of its second purpose-built expedition ship, Seabourn Pursuit , scheduled to launch in August 2023.
  • "Seabourn Pursuit is our newest crown jewel, where guests will experience the perfect blend of ultra-luxury design combined with elevated expedition experiences," said Seabourn President, Natalya Leahy.
  • This state-of-the-art expedition ship is truly a celebration of the creative energy and input of our design collaborator, Tihany Design, and we are proud to welcome Seabourn Pursuit to our ultra-luxury fleet."
  • The overall design scheme of Seabourn Pursuit balances the exploration theme with the comfort and luxury of an expedition vessel.

Sixth Annual Tennessee STEAM Festival Brings Science to Life

Retrieved on: 
Friday, October 7, 2022

Science, technology, engineering, art and math (STEAM) will come to life at events and activities across the state during the 6th annual Tennessee STEAM Festival, taking place Oct. 14-23.

Key Points: 
  • Science, technology, engineering, art and math (STEAM) will come to life at events and activities across the state during the 6th annual Tennessee STEAM Festival, taking place Oct. 14-23.
  • The Festivals popular STEAM-a-Palooza returns this year on Saturday, Oct. 15, from noon to 4 p.m. at the Discovery Center.
  • The Discovery Center at Murfree Spring is a hands-on, environmental, cultural and educational museum located in the heart of Middle Tennessee.
  • More than 120,000 children and families visit annually, exploring exhibits and participating in programs that promote STEAM (science, technology, engineering, arts & math) education.

First-of-its-Kind Mixed-Use Development by Belmont Village Senior Living and Baptist Health South Florida Reaches Construction Milestone in Coral Gables

Retrieved on: 
Thursday, August 25, 2022

Award-winning senior housing developer and operator Belmont Village Senior Living and renowned healthcare organization Baptist Health South Florida announce the topping out of Belmont Village Senior Living Coral Gables on August 25, located at 4111 Salzedo Street.

Key Points: 
  • Award-winning senior housing developer and operator Belmont Village Senior Living and renowned healthcare organization Baptist Health South Florida announce the topping out of Belmont Village Senior Living Coral Gables on August 25, located at 4111 Salzedo Street.
  • Were thrilled to hit this construction milestone on our second Belmont Village community in Florida and the first of many in collaboration with Baptist Health South Florida.
  • To learn more about Belmont Village Senior Living Coral Gables or join the waitlist, visit the Discovery Center located at 4201 So.
  • In addition, it includes Baptist Health Medical Group; Baptist Health Quality Network; and Baptist Health Care On Demand, a virtual health platform.

SEABOURN VENTURE, SEABOURN'S FIRST PURPOSE-BUILT EXPEDITION VESSEL, SETS SAIL FOR ITS FIRST VOYAGE, HEADING FROM THE ARCTIC TO ANTARCTICA OVER THE YEAR AHEAD

Retrieved on: 
Wednesday, July 27, 2022

SEATTLE, July 27, 2022 /PRNewswire/ -- Seabourn, the ultra-luxury ocean and expedition cruise line, is embarking on a new era of adventure on the high seas with the launch of Seabourn Venture. The first of the line's two new ultra-luxury expedition ships, Seabourn Venture entered service and welcomed its first guests on board today, July 27, 2022, on a 12-day Northern Isles expedition, departing Tromsø, Norway, and bound for the Arctic and the Svalbard Archipelago, one of the world's northernmost inhabited areas and home to wildlife from puffins to polar bears.

Key Points: 
  • @SeabournCruise launches its first purpose-built expedition vessel, Seabourn Venture, with an exciting schedule of extraordinary explorations over the year ahead.
  • https://bit.ly/SBN_Venture
    SEATTLE, July 27, 2022 /PRNewswire/ -- Seabourn , the ultra-luxury ocean and expedition cruise line, is embarking on a new era of adventure on the high seas with the launch of Seabourn Venture .
  • Seabourn embarks on a new era of adventure on the high seas with the launch of Seabourn Venture.
  • In March and April 2023, Seabourn Venture will embark on a series of 7- to 12-day expedition voyages in Brazil and the Amazon.

COMPASS Pathways announces changes in Executive Team

Retrieved on: 
Thursday, December 16, 2021

Matthew Owens said: COMPASS is bringing innovation to mental health care, and I am so excited to be joining them.

Key Points: 
  • Matthew Owens said: COMPASS is bringing innovation to mental health care, and I am so excited to be joining them.
  • George Goldsmith, CEO and Co-founder, COMPASS Pathways, said: COMPASS has grown rapidly since its inception in 2016.
  • Our mission and commitment to patients remain the same, but operationally we are a very different company and our executive team is changing to reflect this.
  • COMPASS Pathways plc (Nasdaq: CMPS) is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health.

Belmont Village Senior Living and Baptist Health South Florida Break Ground on Highly Anticipated Coral Gables Community

Retrieved on: 
Wednesday, October 13, 2021

Expanding its presence in South Florida, award-winning senior housing developer and operator Belmont Village Senior Living and Baptist Health South Florida , the largest healthcare organization in the region, together are breaking ground on Belmont Village Coral Gables on Wednesday, October 13th.

Key Points: 
  • Expanding its presence in South Florida, award-winning senior housing developer and operator Belmont Village Senior Living and Baptist Health South Florida , the largest healthcare organization in the region, together are breaking ground on Belmont Village Coral Gables on Wednesday, October 13th.
  • Patricia Will, CEO and Founder of Belmont Village Senior Living, Brian Keely, CEO of Baptist Health South Florida, and Vince Lago, Mayor of the City of Coral Gables, will attend the event celebrating the start of construction for Belmont Villages 33rd community and their first partnership with a renowned healthcare system.
  • We are thrilled to work alongside Belmont Village to deliver a first-of-its-kind, wellness-focused senior living community in Coral Gables, says Ana Lopez-Blazquez, Executive Vice President and Chief Strategy and Transformation Officer, Baptist Health South Florida.
  • In addition, it includes Baptist Health Medical Group; Baptist Health Quality Network; and Baptist Health Care On Demand, a virtual health platform.

COMPASS Pathways plc announces financial results and business highlights for the second quarter 2021

Retrieved on: 
Wednesday, August 11, 2021

This is the largest trial ever conducted in psilocybin therapy, and it was done amid the lockdowns and challenges of the COVID pandemic.

Key Points: 
  • This is the largest trial ever conducted in psilocybin therapy, and it was done amid the lockdowns and challenges of the COVID pandemic.
  • We are well-positioned for recruitment to phase III, pending results from the phase IIb study, which are expected later this year.
  • The call will also be webcast on the investors section of the COMPASS Pathways website ( ir.compasspathways.com ) and archived for 30 days.
  • COMPASS Pathways plc (Nasdaq: CMPS) is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health.